Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

Delayed Data
As of Dec 15
 +3.33 / +2.34%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 25 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Inc have a median target of 185.00, with a high estimate of 205.00 and a low estimate of 85.00. The median estimate represents a +26.83% increase from the last price of 145.86.

Analyst Recommendations

The current consensus among 28 polled investment analysts is to Buy stock in Vertex Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Jan 31

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.30%
Growthannually 121.91%


Growthquarterly 7.53%
Growthannually 26.06%
Key to the earnings and sales forecast charts.